The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test
- 1 November 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pharmacogenetics and Genomics
- Vol. 19 (11), 877-883
- https://doi.org/10.1097/fpc.0b013e32833225e7
Abstract
CYP3A4, CYP3A5 and CYP3A7 are hepatic enzymes that metabolize about 50% of drugs on the market, with a large overlap in their specificities. We investigated the genetic bases that contribute to the variation of CYP3A activity. We phenotyped 251 individuals from two independent studies (182 patients treated with methadone and 69 patients with clozapine) for CYP3A activity using the midazolam phenotyping test and genotyped them for CYP3A4, CYP3A5, and CYP3A7 genetic variants, including the single nucleotide polymorphism (SNP) rs4646437C>T in intron 7 of CYP3A4. Owing to the fact that CYP enzymes require electron transfer through the P450 oxidoreductase (POR), and functional impairment has been shown for the POR*28 SNP, this polymorphism was also analysed. We show that CYP3A4, CYP3A5 and CYP3A7 genotypes, including the SNP rs4646437C>T, do not reflect the inter-individual variability of CYP3A activity (P>0.1). In contrast, POR*28 TT genotype presents a 1.6-fold increase in CYP3A activity compared with POR*28C carriers (n = 182, P = 0.004). This finding was replicated in the second independent dataset (n = 69, P = 0.04). The SNP POR*28 seems to be a better genetic marker of the variability of total CYP3A activity in vivo than CYP3A4, CYP3A5 and CYP3A7 genetic variants.Keywords
This publication has 62 references indexed in Scilit:
- CYP3A7, CYP3A5, CYP3A4, and ABCB1 Genetic Polymorphisms, Cyclosporine Concentration, and Dose Requirement in Transplant RecipientsTherapeutic Drug Monitoring, 2008
- Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African AmericansThe Pharmacogenomics Journal, 2008
- The Common P450 Oxidoreductase Variant A503V Is Not a Modifier Gene for 21-Hydroxylase DeficiencyJournal of Clinical Endocrinology & Metabolism, 2008
- Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutationsProceedings of the National Academy of Sciences of the United States of America, 2008
- Significance of the Minor Cytochrome P450 3A IsoformsClinical Pharmacokinetics, 2006
- The journey from NADPH-cytochrome P450 oxidoreductase to nitric oxide synthasesBiochemical and Biophysical Research Communications, 2005
- Genotype-phenotype associations of cytochrome P450 3A4 and 3A5 polymorphism with midazolam clearance in vivoClinical Pharmacology & Therapeutics, 2005
- The distribution and gender difference of CYP3A activity in Chinese subjectsBritish Journal of Clinical Pharmacology, 2003
- Cloning and Tissue Distribution of a Novel Human Cytochrome P450 of the CYP3A Subfamily, CYP3A43Biochemical and Biophysical Research Communications, 2001
- Cytochrome P450 3AClinical Pharmacokinetics, 1999